Octreotide Acetate is the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone. It is grouped under the following drug class(es): Peptides. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Samilstin, Sandostatin, Octreolin and Mycapssa. Its PubChem CID is 155804637.
Octreotide acetate
| CAS No | 79517-01-4 |
|---|---|
| Molecular Formula | C53H74N10O14S2 |
| Molecular Weight | 1139.3 g/mol |
| Synonyms | acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Octreotide Acetate is the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin.
The listed CAS number is 79517-01-4.
The listed molecular formula is C53H74N10O14S2.
The listed molecular weight is 1139.3 g/mol.
acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide.
The source lists Samilstin, Sandostatin, Octreolin and Mycapssa.